Russell Investments Group
RYTM icon

Russell Investments Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Russell Investments Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.63M Sell
86,709
-29,003
-25% -$2.62M 0.01% 1102
2026
Q1 		$10.1M Sell
115,712
-18,468
-14% -$1.8M 0.01% 934
2025
Q4 		$14.4M Sell
134,180
-23,498
-15% -$2.49M 0.02% 747
2025
Q3 		$15.9M Buy
157,678
+26,680
+20% +$2.48M 0.02% 717
2025
Q2 		$8.28M Buy
130,998
+16,220
+14% +$993K 0.01% 933
2025
Q1 		$6.08M Buy
114,778
+113,781
+11,412% +$6.31M 0.01% 1056
2024
Q4 		$55.8K Buy
997
+3
+0.3% +$166 ﹤0.01% 2795
2024
Q3 		$52.1K Sell
994
-1,016
-51% -$48.7K ﹤0.01% 2783
2024
Q2 		$82.5K Buy
2,010
+1,625
+422% +$64.9K ﹤0.01% 2665
2024
Q1 		$16.7K Buy
+385
New +$16.8K ﹤0.01% 2794
2023
Q3 		– Sell
-1,100
Closed -$18.1K – 3613
2023
Q2 		$18.1K Buy
+1,100
New +$19.9K ﹤0.01% 2857
2020
Q4 		– Sell
-5,891
Closed -$127K – 3172
2020
Q3 		$127K Buy
+5,891
New +$135K ﹤0.01% 2927
2019
Q2 		– Sell
-37,754
Closed -$1.04M – 2939
2019
Q1 		$1.04M Buy
37,754
+3,192
+9% +$91.7K ﹤0.01% 2045
2018
Q4 		$929K Sell
34,562
-3,098
-8% -$85.6K ﹤0.01% 2005
2018
Q3 		$1.1M Sell
37,660
-21,243
-36% -$671K ﹤0.01% 2060
2018
Q2 		$1.84M Sell
58,903
-8,523
-13% -$233K ﹤0.01% 1803
2018
Q1 		$1.34M Buy
+67,426
New +$1.79M ﹤0.01% 2059

Other funds holding RYTM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Russell Investments Group's RYTM Position: Q2 2026 in Review

Russell Investments Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 25% in Q2 2026, selling an estimated $2.62M and leaving 86,709 shares worth $9.63M. The position accounts for 0.01% of the portfolio, ranked #1102.

Russell Investments Group first reported a position in RYTM in Q1 2018 and has held it in 17 quarters since. The position peaked at $15.9M in Q3 2025. 78 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Russell Investments Group held 86,709 shares of Rhythm Pharmaceuticals worth $9.63M as of Q2 2026.
  • Russell Investments Group sold 29,003 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.62M.
  • Rhythm Pharmaceuticals made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1102 holding.
  • Russell Investments Group first reported a position in Rhythm Pharmaceuticals in Q1 2018 and has held it in 17 quarters since.
  • Russell Investments Group's Rhythm Pharmaceuticals position peaked at $15.9M in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.